Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,557 | 10 | 56.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,560 | 4 | 38.2% |
| Travel and Lodging | $1,267 | 2 | 4.6% |
| Food and Beverage | $251.28 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca UK Limited | $15,557 | 10 | $0 (2024) |
| Genentech USA, Inc. | $9,393 | 8 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $2,685 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,520 | 2 | AstraZeneca UK Limited ($1,520) |
| 2023 | $10,278 | 6 | AstraZeneca UK Limited ($10,278) |
| 2022 | $3,759 | 2 | AstraZeneca Pharmaceuticals LP ($2,685) |
| 2021 | $2,685 | 1 | AstraZeneca UK Limited ($2,685) |
| 2020 | $396.90 | 1 | Genentech USA, Inc. ($396.90) |
| 2019 | $8,996 | 7 | Genentech USA, Inc. ($8,996) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $1,074.00 | General |
| 02/29/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $445.71 | General |
| 11/06/2023 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $1,755.99 | General |
| 08/04/2023 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $1,970.79 | General |
| 06/23/2023 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $268.50 | General |
| 06/19/2023 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $4,027.50 | General |
| 03/28/2023 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $912.90 | General |
| 03/14/2023 | AstraZeneca UK Limited | ENHERTU (Biological) | Consulting Fee | Cash or cash equivalent | $1,342.50 | General |
| Category: Oncology | ||||||
| 12/13/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $2,685.00 | General |
| Category: Oncology | ||||||
| 05/16/2022 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $1,074.00 | General |
| 07/06/2021 | AstraZeneca UK Limited | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,685.00 | General |
| 03/25/2020 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $396.90 | General |
| 12/09/2019 | Genentech USA, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,875.00 | General |
| 12/09/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $114.57 | General |
| 12/03/2019 | Genentech USA, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| 10/30/2019 | Genentech USA, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,600.00 | General |
| 10/30/2019 | Genentech USA, Inc. | — | Travel and Lodging | Cash or cash equivalent | $870.10 | General |
| 10/30/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $88.47 | General |
| 06/18/2019 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $48.24 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 3,134 | 4,419 | $284,320 | $53,234 |
| 2022 | 6 | 3,353 | 4,298 | $341,660 | $66,055 |
| 2021 | 6 | 3,496 | 4,534 | $405,785 | $82,129 |
| 2020 | 8 | 3,749 | 6,651 | $517,481 | $100,175 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 1,564 | 2,803 | $112,120 | $19,199 | 17.1% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 156 | 161 | $33,810 | $6,509 | 19.3% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 87 | 89 | $28,925 | $5,946 | 20.6% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 121 | 121 | $25,410 | $5,050 | 19.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 604 | 620 | $24,800 | $4,633 | 18.7% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 114 | 117 | $22,815 | $4,615 | 20.2% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 87 | 88 | $17,160 | $3,322 | 19.4% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 385 | 404 | $16,160 | $3,146 | 19.5% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 16 | 16 | $3,120 | $815.36 | 26.1% |
| 71045 | X-ray of chest, 1 view | Facility | 2022 | 1,479 | 2,354 | $94,030 | $16,268 | 17.3% |
| 71260 | Ct scan of chest with contrast | Office | 2022 | 269 | 281 | $56,200 | $10,640 | 18.9% |
| 71260 | Ct scan of chest with contrast | Facility | 2022 | 212 | 220 | $44,000 | $8,924 | 20.3% |
| 71250 | Ct scan of chest without contrast | Facility | 2022 | 195 | 200 | $37,990 | $7,821 | 20.6% |
| 71250 | Ct scan of chest without contrast | Office | 2022 | 184 | 185 | $35,145 | $6,924 | 19.7% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2022 | 94 | 96 | $30,715 | $6,551 | 21.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 473 | 480 | $19,200 | $3,648 | 19.0% |
| 71046 | X-ray of chest, 2 views | Facility | 2022 | 413 | 448 | $17,920 | $3,512 | 19.6% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2022 | 34 | 34 | $6,460 | $1,768 | 27.4% |
| 71260 | Diagnostic ct scan of chest with contrast | Office | 2021 | 422 | 470 | $94,000 | $19,380 | 20.6% |
| 71045 | X-ray of chest, 1 view | Facility | 2021 | 1,493 | 2,407 | $84,245 | $17,110 | 20.3% |
| 71260 | Diagnostic ct scan of chest with contrast | Facility | 2021 | 288 | 302 | $60,400 | $12,633 | 20.9% |
| 71250 | Diagnostic ct scan of chest | Facility | 2021 | 231 | 241 | $44,585 | $9,487 | 21.3% |
| 71275 | Ct scan of blood vessels in chest with contrast | Facility | 2021 | 117 | 120 | $37,800 | $8,185 | 21.7% |
| 71250 | Diagnostic ct scan of chest | Office | 2021 | 194 | 199 | $36,815 | $7,737 | 21.0% |
| 71046 | X-ray of chest, 2 views | Facility | 2021 | 367 | 405 | $16,200 | $3,245 | 20.0% |
About Edwin Donnelly, MD, PHD
Edwin Donnelly, MD, PHD is a Diagnostic Radiology healthcare provider based in Powell, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215029632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edwin Donnelly, MD, PHD has received a total of $27,635 in payments from pharmaceutical and medical device companies, with $1,520 received in 2024. These payments were reported across 19 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($15,557).
As a Medicare-enrolled provider, Donnelly has provided services to 13,732 Medicare beneficiaries, totaling 19,902 services with total Medicare billing of $301,592. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Powell, OH
- Active Since 09/30/2006
- Last Updated 08/26/2025
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1215029632
Products in Payments
- TAGRISSO (Drug) $2,685
- ENHERTU (Biological) $1,343
- Xolair (Biological) $48.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Powell
Dr. Michael Lahm, M.d, M.D
Diagnostic Radiology — Payments: $2,300
Dr. Charles Muncrief, D.o, D.O
Diagnostic Radiology — Payments: $586.44
Antony Roberts, Do, DO
Diagnostic Radiology — Payments: $141.05
Lawrence Dirksen, M.d, M.D
Diagnostic Radiology
Dr. Donald Simon, M.d, M.D
Diagnostic Radiology
Dr. S. Haas, M.d, M.D
Diagnostic Radiology